Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization Adds a major

Amneal completes Kashiv BioSciences acquisition

Amneal Pharmaceuticals has completed its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars business with capabilities across research, development, manufacturing and commercialisation. The combination establishes one of the industry’s few fully integrated biosimilars platforms, the company said. “The completion of this acquisition marks a pivotal step in Amneal’s strategy to become America’s #1 Affordable Med…